Streetbeat News

Analyst Ratings

MSA

William Blair analyst Lawrence De Maria has upgraded MSA Safety (NYSE:MSA) from Market Perform to Outperform.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:35 am

VTEX

Credit Suisse analyst Daniel Federle downgraded Vtex (NYSE:VTEX) from Outperform to Neutral and lowered the price target from $6.5 to $5.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:27 am

KMX

Northcoast Research analyst John Healy has downgraded CarMax (NYSE:KMX) from Buy to Neutral.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:26 am

SIG

Northcoast Research analyst Tim Vierengel has downgraded Signet Jewelers (NYSE:SIG) from Buy to Neutral.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:24 am

ALLY

Odeon Capital has initiated coverage on Ally Financial (NYSE: ALLY) with a Sell rating and a price target of $25.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:23 am

CNTA

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating and announces a price target of $9.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:22 am

AMD

Rosenblatt analyst Hans Mosesmann reiterated a Buy rating on Advanced Micro Devices (NASDAQ:AMD) and maintained a $200 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:17 am

JSPR

EF Hutton analyst Michael King reiterated a Buy rating on Jasper Therapeutics (NASDAQ:JSPR) and maintained a $6.85 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:15 am

KE

EF Hutton analyst Tim Moore initiates coverage on Kimball Electronics (NASDAQ:KE) with a Buy rating and announces a price target of $37.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:14 am

BIIB

Needham analyst Ami Fadia reiterates a Buy rating on Biogen (NASDAQ:BIIB) and maintains a $321 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:12 am